|
|
|
|
New Treatment Hope For People With Recurring Depression
Research shows for the first time that a group-based psychological treatment, Mindfulness Based Cognitive Therapy (MBCT), could be a viable alternative to prescription drugs for people suffering from long-term depression.In a study,...
|
|
|
Mother who killed her own two children was not treated for mental health problems 'because she failed to keep
A mother accused of killing her baby and two-year-old son had been treated for mental health problems - but was discharged because she failed to keep appointments.Doctors at Manchester Mental Health and Social Care diagnosed Jael Mullings...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA - News) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
In the same issue of The Lancet, in an accompanying editorial, 'Let there be sleep -- on time,' Cardinali and Golombek(2) discuss the implications of the circadian regulatory and sleep-promoting effects of tasimelteon.They also point to...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA - News) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
/PRNewswire-FirstCall via COMTEX/ -- Vanda Pharmaceuticals Inc.(VNDA: VNDA News, chart, profile, more Last: Delayed quote data Add to portfolio Analyst Create alert Insider Discuss Financials Sponsored by: , , ) reports publication in The...
|
|
|
Acupuncture just as effective without needle penetration
Medical Research News Acupuncture works - but it works equally well with or without needle penetration.This conclusion can be drawn from a treatment study involving cancer patients suffering from nausea during radiotherapy. Anna Enblom,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
/PRNewswire-FirstCall via COMTEX/ -- VNDA | Quote | Chart | News | PowerRating -- Vanda Pharmaceuticals Inc.(Nasdaq: VNDA | Quote | Chart | News | PowerRating) reports publication in The Lancet, one of the world's leading medical journals...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
Vanda Pharmaceuticals Inc.(Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental compound tasimelteon (VEC-162). The...
|
|
|
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteo
ROCKVILLE, Md., Dec.1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator,...
|
